MEI Pharma, Inc. Quarterly Operating Lease, Payments in USD from Q4 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
MEI Pharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q4 2019 to Q1 2024.
  • MEI Pharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $584K, a 3% increase year-over-year.
  • MEI Pharma, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $2.32M.
  • MEI Pharma, Inc. annual Operating Lease, Payments for 2023 was $2.27M, a 49.2% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.32M $584K +$17K +3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.3M $583K +$16K +2.82% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $2.28M $584K +$17K +3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.27M $566K Apr 1, 2023 Jun 30, 2023 10-K 2023-09-26
Q1 2023 $567K +$187K +49.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $567K +$187K +49.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $567K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q1 2022 $380K +$11K +2.98% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $380K +$257K +209% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q1 2021 $369K +$168K +83.6% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $123K -$78K -38.8% Oct 1, 2020 Dec 31, 2020 10-Q 2021-02-04
Q1 2020 $201K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $201K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.